InflaRx Competitors and Similar CompaniesClear all
InflaRx's competitors and similar companies include CorMedix.
 InflaRx InflaRx is a biopharmaceutical company developing new therapeutics in the field of acute and chronic inflammation. |  CorMedix CorMedix is a pharmaceutical company that seeks to in-license, develop and commercialize therapeutic products for the treatment of cardiac and kidney disease. | |
Founding Date | Founding Date 2006 | Founding Date 2006 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Jena, DE HQ Planegg, DE | Locations Berkeley Heights, US HQ |
Employees | Employees 74 | Employees 3036% increase |
Valuation ($) | Valuation ($) 92.2 m | Valuation ($) 749.2 m |
Financial | ||
Revenue (est.) | Revenue (est.) €29k (FY, 2025) | Revenue (est.) $311.7m (FY, 2025) |
Cost of goods | Cost of goods €7.2m (FY, 2025) | Cost of goods $22.1m (FY, 2025) |
Gross profit | Gross profit (€4.5m) (FY, 2025) | Gross profit $275.7m (FY, 2025) |
Net income | Net income (€45.6m) (FY, 2025) | Net income $163.1m (FY, 2025) |
Funding | ||
Total funding raised | Total funding raised $ 89m | Total funding raised $ 11.5m |
For sources of this data, please see the company profile
View Company Profiles
CorMedix
HQ
Berkeley Heights, US
Employees
30↑ 36% increase
CorMedix is a pharmaceutical company that seeks to in-license, develop and commercialize therapeutic products for the treatment of cardiac and kidney disease.
View company